It was demonstrated that bladder cancer cells were sensitized to ferroptosis by p53 pharmacological activation or ALOX15B overexpression, whereas ALOX15B silencing had the opposite effect [181]. This evidence concerns the gene TP53 and urinary bladder carcinoma.